Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

Thumbnail

FDA grants breakthrough device designation to AI-powered ECG analysis tool

Tempus, a Chicago-based healthcare technology company, collaborated with Geisinger on the solution.

Thumbnail

AI model predicts death from cardiovascular disease, coronary artery disease better than other advanced techniques

The analysis, published in JACC: Cardiovascular Imaging, included clinical data and non-contrast CT findings from more than 66,000 patients. 

Thumbnail

Lawsuit claims stroke patient waited more than 6 hours for CT read, leading to permanent brain damage

The complaint alleges two Tampa Bay, Florida-area healthcare groups did not abide by their own stated policies after a scan was ordered to be completed "STAT."

Combined imaging method overcomes angiogram limitations and may help prevent heart attacks

Pairing near-infrared spectroscopy and intravascular ultrasound spotted more than 3,600 untreated plaques missed by other diagnostic and clinical tests, according to a new prospective study.

Thumbnail

Wearable ECG devices detect AFib among older patients, reducing the risk of stroke

The new study, published in JAMA Cardiology, included more than 800 hypertension patients aged 75 years or older. 

chest pain lung pulmonary embolism

New pulmonary embolism approach could substantially reduce imaging overuse

The pretest probability score produced false-negative rates below 1% and dropped imaging use by about 20%, according to a new JAMA Cardiology study. 

Thumbnail

Radiologists reporting CAC during lung cancer screening can strengthen preventative statin prescribing

Coronary artery calcification is a marker of atherosclerotic cardiovascular disease, the leading killer in patients undergoing low-dose CT screening.

Thumbnail

CTA provides value as a noninvasive alternative to ICA when treating NSTE-ACS

These latest findings are based on data from the VERDICT trial.